The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostics factors in previously untreated urothelial cancer patients ineligible for cisplatin-based chemotherapy: An external validation of the Bajorin risk groups.
Sandra Collette
No relevant relationships to disclose
Richard Sylvester
No relevant relationships to disclose
Joaquim Bellmunt
No relevant relationships to disclose
Graham Mead
No relevant relationships to disclose
Jan M. Kerst
No relevant relationships to disclose
Michael Gordon Leahy
No relevant relationships to disclose
Pablo Maroto
No relevant relationships to disclose
Thierry Gil
No relevant relationships to disclose
Sandrine Marreaud
No relevant relationships to disclose
Gedske Daugaard
No relevant relationships to disclose
Iwona Anna Skoneczna
No relevant relationships to disclose
Ronald De Wit
No relevant relationships to disclose
Maria De Santis
No relevant relationships to disclose